LYON, France--(BUSINESS WIRE)-- Regulatory News: Adocia (Paris:ADOC) (Euronext Paris: FR0011184241 – ADOC, the “Company”), the biopharmaceutical company focused on the treatment of diabetes and other ...
INDIANAPOLIS, June 15, 2020 /PRNewswire/ -- The U.S. Food and Drug Administration (FDA) has approved Lyumjev™ (insulin lispro-aabc injection, 100 units/mL and 200 units/mL), Eli Lilly and Company's ...
This week, the FDA approved LYUMJEV (insulin lispro-aabc), a new insulin lispro product by Lilly. LYUMJEV is a formulation of insulin lispro, developed to speed the absorption of insulin into the ...
New Rochelle, NY, August 9, 2017--A study comparing the safety and efficacy of SAR342434, a biosimilar (follow-on form) of insulin lispro-Humalog®, found it to be comparable to that of the brand name ...
The Price section compares costs of the same generic drugs across brands and is purely for information purpose. Medindia neither buys nor sells drugs. Insulin Lispro (Humalog (3ml)) is a fast acting ...
The purpose of the comparative study is to demonstrate safety and efficacy of BioChaperone Lispro (BC Lispro) using Tonghua Dongbao (THDB) lispro as the drug substance. In nine previous studies, BC ...
INDIANAPOLIS, April 16, 2020 /PRNewswire/ -- Non-branded versions of Humalog® Mix75/25™ KwikPen® (insulin lispro protamine and insulin lispro injectable suspension, 100 units/mL) and ...
Please provide your email address to receive an email when new articles are posted on . In reporting findings from the phase 2b Insulin Liver Effect (ISLE-1) trial, the researchers also found that ...
Eli Lilly is continuing to work to lower the out-of-pocket costs for people using insulin. The company announced that it is lowering the list price of Insulin Lispro Injection by an additional 40% ...
Insulin Lispro (Humalog (3 ml)) is a fast acting insulin analogue, prescribed for type 1 diabetes. The information provided on this page is intended to serve as a comprehensive resource and should not ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results